Figure 11.1

ESRD expenditures, by payer
[Download]

Figure 11.2

Costs of the Medicare & ESRD programs
[Download]

Figure 11.3

Estimated numbers of point prevalent ESRD patients
[Download]

Figure 11.4

Annual percent change in Medicare ESRD spending
[Download]

Figure 11.5

Total Medicare dollars spent on ESRD, by type of service
[Download]

Figure 11.6

Total Medicare ESRD expenditures, by modality
[Download]

Figure 11.7

Total Medicare ESRD expenditures per person per year, by modality
[Download]

Figure 11.8

Per person per year (PPPY) inpatient/outpatient & physician/supplier net costs for Medicare & Truven Health MarketScan (EGHP) patients with ESRD
[Download]

Figure 11.9

Total per person per year outpatient expenditures, by race
[Download]

Figure 11.10

Total Part D net costs, by low income subsidy (LIS) status, 2011
[Download]

Figure 11.11

Total per person per year Part D net & out-of pocket costs, by low income subsidy (LIS) status, 2011
[Download]

Figure 11.12

Total per person per year Part D costs, by low income subsidy (LIS) status & provider, 2011
[Download]

Figure 11.13

Total per person per year (PPPY) Part D costs for phosphate binders, by provider, 2011
[Download]

Figure 11.14

Total per person per year (PPPY) Part D costs for cinacalcet, by provider, 2011
[Download]

Figure 11.15

Total per person per year (PPPY) Part D costs for antihypertensives, by provider, 2011
[Download]

Figure 11.16

Total per person per year (PPPY) Part D costs for diabetes agents, by provider, 2011
[Download]